Interferon-mediated activation of the STAT signaling pathway in a human carcinoid tumor

S Wang1, S K Tyring, C M Townsend

  • 1Department of Surgery, People's Hospital, Beijing Medical University, China.

Annals of Surgical Oncology
|November 27, 1998
PubMed
Abstract

Insights

Interferons (IFNs) activate Signal Transducers and Activators of Transcription (Stat) proteins, influencing human cancer growth. This study shows IFNs increase Stat protein levels and DNA binding in pancreatic carcinoid tumor cells.

Area of Science:

  • Oncology
  • Molecular Biology
  • Immunology

Background:

  • Interferons (IFNs) inhibit human cancers, including endocrine tumors, but mechanisms are unclear.
  • IFNs activate Signal Transducers and Activators of Transcription (Stat) proteins, which regulate gene expression.
  • Understanding these pathways is crucial for developing IFN-based cancer therapies.

Purpose of the Study:

  • To investigate the effect of IFN-alpha and IFN-gamma on the Stat signaling pathway.
  • To utilize a unique human pancreatic carcinoid tumor model (BON cells).
  • To elucidate mechanisms of IFN-mediated growth inhibition in endocrine tumors.

Main Methods:

  • BON cells were treated with IFN-alpha or IFN-gamma.
  • Nuclear proteins were extracted at specific time points.
  • Western blot and electrophoretic mobility shift assay (EMSA) were used to measure Stat protein levels and DNA binding.

Main Results:

  • IFN-alpha increased Stat3 and Stat5 protein levels and DNA binding.
  • IFN-gamma elevated Stat1, Stat3, and Stat5 protein levels within 24-48 hours.
  • Both IFNs enhanced Stat3 and Stat5 binding activity to DNA consensus sites.

Conclusions:

  • IFN-alpha and IFN-gamma induce Stat protein binding and increase Stat protein levels in BON cells.
  • These findings clarify Stat pathway activation by IFNs in endocrine tumors.
  • Further research will identify downstream targets and mechanisms of IFN-induced tumor growth inhibition.

Related Concept Videos

NF-κB-dependent Signaling Pathway02:26

NF-κB-dependent Signaling Pathway

The transcription factor NF-κB was discovered in 1986 in the lab of Nobel laureate Professor David Baltimore, for its interaction with the immunoglobulin light chain enhancer in B-cells. After more than three decades of study, it is now evident that NF-κB regulates the expression of over 100 genes. Most of these genes play an essential role in the innate and adaptive immune responses as well as the inflammatory responses of animals.
NF-κB-dependent Signaling Mechanism
The heterodimer of NF-κB...
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
Receptor Downregulation in MVBs01:15

Receptor Downregulation in MVBs

Multivesicular bodies (MVBs) are mature endosomes that sort ubiquitinated proteins and then fuse with lysosomes to degrade the sorted proteins. Epidermal growth factor (EGF) and its receptor (EGFR) form a complex that can be internalized through endocytosis, sorted into an MVB, and later degraded.
The EGFR can initiate signaling pathways that  lead to cell proliferation, migration, and differentiation. Overexpression of EGFR  stimulates cells to proliferate. Excessive  EGFR activation may...
Interactions Between Signaling Pathways01:19

Interactions Between Signaling Pathways

Signaling cascades usually lack linearity. Multiple pathways interact and regulate one another, allowing cells to integrate and respond to diverse environmental stimuli.
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
The JAK-STAT Signaling Pathway01:20

The JAK-STAT Signaling Pathway

Several cytokine receptors have tightly bound Janus kinase or JAK proteins attached at their cytosolic tail. Small signaling molecules such as cytokines, growth hormones, or prolactins bind to the cytokine receptors and initiate their dimerization. The dimerization brings the cytosolic JAKs together that trans-phosphorylate and activates each other. The activated JAKs now phosphorylate cytosolic tails of the cytokine receptors, which serve as binding sites for adaptor proteins such as  SH2...
Intracellular Signaling Affects Focal Adhesions01:17

Intracellular Signaling Affects Focal Adhesions

Integrins act both as extracellular input receivers and as intracellular processing activators. As their name suggests, integrins are entirely integrated into the membrane structure. Their hydrophobic membrane-spanning regions interact with the phospholipid bilayer's hydrophobic region. These membrane receptors provide extracellular attachment sites for effectors like hormones and growth factors. They activate intracellular response cascades when their effectors are bound and active.
Some...